We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Many drugs are available for hypertension, with more in development

    Hypertension is a global health issue that is associated with an increased risk for poor cardiovascular outcomes and kidney failure. A wide range of...

    Article 15 November 2022
  2. Hypertension self-care practice and its associated factors in Bale Zone, Southeast Ethiopia: A multi-center cross-sectional study

    Background

    Hypertension is a serious threat to public health globally owing to its high prevalence and related complications. It is the main risk...

    Dagmawi Teshome Tebelu, Tesfaye Assefa Tadesse, ... Abenet Menene Gurara in Journal of Pharmaceutical Policy and Practice
    Article Open access 02 February 2023
  3. Polypill Concept in the Treatment of Arterial Hypertension (Review)

    This review discusses relevant issues of antihypertensive therapy with fixed-dose combination pills (polypills). Special features of polypills are...

    K. M. Tserkovnaya, Yu. M. Kotsur, ... I. A. Narkevich in Pharmaceutical Chemistry Journal
    Article 17 August 2022
  4. Hypoxia-inducible factors and essential hypertension: narrative review of experimental and clinical data

    Hypoxia-inducible factor (HIFs) is a new class of drug developed for the management of anemia in chronic kidney disease (CKD) patients. HIFs increase...

    Baris Afsar, Rengin Elsurer Afsar in Pharmacological Reports
    Article 21 May 2023
  5. Cannabidiol may prevent the development of congestive hepatopathy secondary to right ventricular hypertrophy associated with pulmonary hypertension in rats

    Background

    Pulmonary hypertension (PH) can cause right ventricular (RV) failure and subsequent cardiohepatic syndrome referred to as congestive...

    Anna Krzyżewska, Marta Baranowska-Kuczko, ... Hanna Kozłowska in Pharmacological Reports
    Article Open access 22 March 2024
  6. Dapagliflozin attenuates myocardial remodeling in hypertension by activating the circadian rhythm signaling pathway

    Sodium-glucose cotransporter 2 inhibitor (SGLT2i) is a new kind of antidiabetic drug which has shown beneficial effects in reducing heart...

    **g Wang, Qiang She, Jianlin Du in Archives of Pharmacal Research
    Article 02 February 2023
  7. Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru

    Background

    Regular measurement of the availability and use of key medicines for non-communicable diseases allows the tracking of progress to achieve...

    Janeth Tenorio-Mucha, María Lazo-Porras, ... David Beran in Journal of Pharmaceutical Policy and Practice
    Article Open access 18 November 2022
  8. Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records

    Background

    Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines...

    Mohamed Ahmed Syed, Ahmed Sameer Al Nuaimi, ... Uzma Razaq in Journal of Pharmaceutical Policy and Practice
    Article Open access 11 August 2021
  9. Severe hypertension in children needs a rapid response and thorough investigation

    Severe hypertension (HTN) in children requires urgent treatment. If end organ renal, neurological or cardiac damage is suspected, intravenous...

    Caroline Fenton, Connie Kang in Drugs & Therapy Perspectives
    Article 06 October 2020
  10. Evaluation of management and factors associated with hypertension control in hemodialysis patients at a tertiary-care hospital in Pakistan

    Background

    Hypertension is highly prevalent and poorly controlled among hemodialysis patients. However, published information regarding the management...

    Gulalai, Nafees Ahmad, ... Asad Khan in Drugs & Therapy Perspectives
    Article 28 July 2020
  11. Protective effect of nicotinamide and l-arginine against monocrotaline-induced pulmonary hypertension in rats: gender dependence

    Background

    The purpose of this paper was to examine the effects of nicotinamide (ND) and l -arginine ( l -ARG) on pulmonary vascular and heart changes...

    Katarzyna Sztormowska-Achranowicz, Zbigniew Jankowski, Ivan Kocić in Pharmacological Reports
    Article Open access 06 July 2020
  12. Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19

    COVID-19 has recently become a major pandemic with associated socioeconomic dimensions. Mortality statistics suggest that COVID-19 is more lethal in...

    Sikandar Hayat Khan, Sabeen Khurshid Zaidi in Drugs & Therapy Perspectives
    Article 09 June 2020
  13. Self-care practice among adult hypertensive patients at ambulatory clinic of tertiary teaching Hospital in Ethiopia: a cross-sectional study

    Background

    Globally, hypertension is a major public health problem and a strong predictor of cardiovascular disease complications. To reduce and...

    Tsegaye Melaku, Bodena Bayisa, ... Alemayehu Gutasa in Journal of Pharmaceutical Policy and Practice
    Article Open access 22 March 2022
  14. Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia

    Background

    Vascular dementia is the second most prevalent form of dementia. Hypertension is the leading risk factor for endothelial dysfunction and...

    Poonam Sharma, Nikita Gaur, ... Bhupesh Sharma in Pharmacological Reports
    Article 09 April 2022
  15. Over-Prescription of the Imidazoline Receptor Agonists: Evidence for Restriction of the Therapeutic Indication

    Background

    Major antihypertensive drug classes (but not Imidazoline Receptor Agonists) have been demonstrated to reduce cardiovascular morbidity and...

    Rimas Jankūnas, Diana Rinkūnienė, Donatas Stakišaitis in Therapeutic Innovation & Regulatory Science
    Article 30 July 2022
  16. Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study

    Objectives

    Existing literature does not provide enough information on evaluation of factors associated with pre-dialysis controlled hypertension among...

    Amjad Khan, Amer Hayat Khan, ... Irfanullah Khan in Journal of Pharmaceutical Policy and Practice
    Article Open access 14 May 2019
  17. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list

    Background

    Globally, cardiovascular disease (CVD) is a leading cause of death and disproportionately affects low- and middle-income countries (LMICs)....

    Ian Naicker, Fatima Suleman, Velisha Ann Perumal-Pillay in Journal of Pharmaceutical Policy and Practice
    Article Open access 08 December 2022
  18. Don’t overlook monoamine oxidase inhibitors in psychiatric practice

    Monoamine oxidase inhibitors (MAOIs), including phenelzine, tranylcypromine, moclobemide and selegiline are established and effective antidepressants...

    Caroline Fenton, Arnold Lee in Drugs & Therapy Perspectives
    Article 01 May 2022
  19. Acute coronary syndrome and its treatment outcomes in Ethiopia: a systematic review and meta-analysis

    Background

    Acute coronary syndrome (ACS) is the principal cause of death in develo** countries including Ethiopia. No study reports the overall...

    Bekalu Kebede, Melese Getachew, ... Yoseph Merkeb Alamneh in Journal of Pharmaceutical Policy and Practice
    Article Open access 07 August 2023
  20. Evaluation of diclofenac utilization patterns before and after digital risk minimization intervention in outpatient settings in Montenegro

    Introduction

    Risk minimization measures are one of the most important tools in ensuring safe use of medicines. The evaluation of their effectiveness...

    Maja Stankovic, Nemanja Turkovic, ... Nemanja Rancic in Drugs & Therapy Perspectives
    Article 24 February 2024
Did you find what you were looking for? Share feedback.